APA (7th ed.) Citation

WJ, K., BJ, K., C, L., TY, K., G, H., Y, C., . . . CS, H. (2024). B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice. Gut microbes, 16(1), 2319889. https://doi.org/10.1080/19490976.2024.2319889

Chicago Style (17th ed.) Citation

WJ, Kim, et al. "B. Longum CKD1 Enhances the Efficacy of Anti-diabetic Medicines Through Upregulation of IL- 22 Response in Type 2 Diabetic Mice." Gut Microbes 16, no. 1 (2024): 2319889. https://doi.org/10.1080/19490976.2024.2319889.

MLA (9th ed.) Citation

WJ, Kim, et al. "B. Longum CKD1 Enhances the Efficacy of Anti-diabetic Medicines Through Upregulation of IL- 22 Response in Type 2 Diabetic Mice." Gut Microbes, vol. 16, no. 1, 2024, p. 2319889, https://doi.org/10.1080/19490976.2024.2319889.